TRAF2 and acute respiratory distress syndrome: To sum up, we identified TRIM47 is a novel activator of endothelial cells, in which it mediates inflammatory response and promotes inflammation and tissue damage during ALI through activating endothelial TRAF2-MAPK/NF-κB pro-inflammatory axis (Fig. 7e).